Latest Articles
- Putting the latest data into practice
This supplement is based on the proceedings of a roundtable convened at the Cleveland Clinic on January 17, 2008, by the Cleveland Clinic Journal of Medicine.
An elderly woman with shortness of breathHer dyspnea started about 6 months ago and has recently worsened. What is the cause?
- Perioperative management of bariatric surgery patients: Focus on metabolic bone disease
Obese people are at risk of low bone mass to begin with, and bariatric surgery increases the risk. Primary care physicians play an important role in their preventive care.
- How safe are erythropoiesis-stimulating agents?
The year 2007 was a rough one for these agents, and the story is far from over.
- ‘Blood will have blood’
Why should more patients die when hemoglobin levels are normalized with erythropoiesis-stimulating agents? It could be another case of “messing with Mother Nature.”
- Anemia of chronic kidney disease: When normalcy becomes undesirable
Several recent studies indicate that raising hemoglobin levels to the normal range with erythropoiesis-stimulating agents can be too much of a good thing, and the US Food and Drug Administration has issued a warning on the use of these drugs in renal disease.
- Thrombotic thrombocytopenic purpura: 2008 Update
This is one of the few hematologic emergencies. Untreated, most patients die, but prompt treatment allows most patients not only to survive but to recover.